Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:07 AM ・ 2 min read ・ Source: PR Times
Maxigen Biotech Inc. (code: 1783), a biotechnology and medical care company, announced its May 2026 revenue of NT$73,604 thousand (approx. NT$74 million), representing a 4.4% decrease compared to the same period last year.
Company Code: 1783 Company Name: Maxigen Biotech Inc. Industry: Biotechnology and Medical Care Data Month/Year: May 2026 Monthly Revenue: NT$73,604 thousand (approx. NT$74 million) YoY Change: -4.4%
This monthly revenue report highlights the financial performance of Maxigen Biotech Inc. for May 2026, showing a slight year-over-year decline.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.